Powered by Q1Group LLC
Education and Decision Support Tools for the Medicare Community


April 2013 Summary of the Most Recent Updates for the Medicare Part D Plan Formularies (Drug Lists)

Category: Monthly Formulary Changes
Published on 2013-04-19 09:10:02


The most recent (April 2013) Medicare Part D plan formulary data (or drug lists) updates include the addition of 267 new National Drug Codes (NDC) to the Medicare Part D program.  These represent 163 different drugs, many with multiple strengths or delivery forms.

The NDC uniquely identifies a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.

There are many reasons for NDCs to be added to the Medicare Part D program, a summary is a follows:

Reason for NDC Addition Occurences
new delivery form 4
new drug 49
new drug strength 62
new drug with multiple strengths 86
new drug strength and delivery form 3
new drug form 2
new drug form with multiple strengths 2
new manufacturer 30
new manufacturer/new delivery form 1
new manufacturer/new drug strength 17
new manufacturer/new drug 0
new manufacturer/new drug strength/new form 0
new package 2
new package size 6
new product code 3

The majority of the 267 new NDCs included new drug strengths and in some cases manufacturers. Seven new generic alternatives were introduced:

  • CEVIMELINE HCL generic equivalent for Evoxac® is on 37 PDP and 169 MAPD formularies
  • CIDOFOVIR generic equivalent for Vistide® is on 24 PDP and 140 MAPD formularies
  • MODAFINIL generic equivalent for Provigil® is on 58 PDP and 219 MAPD formularies
  • MONTELUKAST SODIUM generic equivalent for Singulair® is on 66 PDP and 235 MAPD formularies
  • PIOGLITAZONE HCL generic equivalent for Actos® is on 63 PDP and 220 MAPD formularies
  • TIAGABINE HCL generic equivalent for Gabitril® is on 60 PDP and 200 MAPD formularies
  • TOLTERODINE TARTRATE generic equivalent for Detrol LA® is on 54 PDP and 200 MAPD formularies
The following 267 manufacturer / drug / strength / packaging combinations (NDCs) were added to one or more Medicare Part D formularies in the most recent updates. You can click on the NDC or Drug Name below to go to our Q1Medicare.com DrugFinder to see the details of how this drug is handled by all Medicare Part D Plans in Florida -- You can then change the state to your state for details in your service area.

NDC Drug Name Notes
00378410591 ABACAVIR 300 MG TABLET new drug
10631011531 ABSORICA 10 MG CAPSULE new drug/strength
64764030115 Actos 30mg/90 Tablet Bottle new package
60505530601 acyclovir 400mg/1 new manufacturer
27505000200 ALSUMA 6mg/0.5mL 2 SYRINGE in 1 PACKAGE / 0.5 mL in 1 SYRINGE new drug
00409195701 AMIKACIN Sulfate 1g/4mL 10 VIAL, SINGLE-DOSE in 1 CARTON / 4 mL in 1 VIAL, SINGLE-DOSE new strength
66685101102 amox tr-k clv 200-28.5/5 susp new manufacturer/strength
00781340095 Ampicillin 125mg/1 10 VIAL, GLASS in 1 PACKAGE / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS new manufacturer/strength
52544007660 ANDRODERM 2 MG/24HR PATCH new drug/strength
00187090201 ANDROID 10 MG CAPSULE new drug
00088250033 APIDRA 100 UNITS/ML VIAL new drug
27505000405 APOKYN 30 MG/3 ML CARTRIDGE new manufacturer
58468021002 AUBAGIO 14 MG TABLET new drug/strength
50458021101 AXERT 6.25 MG TABLET new drug/strength
42806003801 Betaxolol 10mg/1 new strength
64679096601 BETHANECHOL 10 MG TABLET new strength
00069013501 BOSULIF 100 MG TABLET new drug/strength
00781711783 CALCIPOTRIENE 0.005% CREAM new manufacturer
00378300177 candesartan-hctz 16-12.5 mg tablet new drug/strength
51672412501 CARBAMAZEPINE XR 400 MG TABLET new strength
00187079247 CARDIZEM 120 MG TABLET new form
00143993122 Cefotaxime 1g/1 25 INJECTION in 1 PACKAGE new strength
68180030220 cefuroxime axetil 250mg/1 new strength
60505314505 CEVIMELINE HCL 30 MG CAPSULE new drug
45043087640 Chenodal 250mg/1 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC new drug
00781591501 CHLORPROMAZINE 50 MG TABLET new product code
23155021631 cidofovir 375 mg/5 ml vial new drug
00009076004 Cleocin Pediatric 75mg/5mL 75 mL in 1 BOTTLE new drug
00093083201 Clonazepam 0.5mg/1 100 TABLET BOTTLE new strength
00093777201 Clozapine 100mg/1 100 TABLET BOTTLE new manufacturer
76478061102 COGENTIN 2 MG/2 ML AMPULE new drug
64764011901 COLCRYS 0.6 MG TABLET new manufacturer
00597002402 COMBIVENT RESPIMAT INHAL SPRAY new package
45963043965 CONSTULOSE 10 GM/15 ML SOLN new drug
68025005330 ConZip 100mg/1 new drug/strength
00378401701 DESLORATADINE 5 MG TABLET new drug
51672128103 DESONIDE 0.05% OINTMENT new manufacturer
51672135207 desoximetasone 0.05% ointment new strength
00228305911 DEXTROAMP-AMPHET ER 10 MG CAP new drug/strength
00591039860 diclofenac-misoprost 75-0.2 tablet new drug/strength
76478071140 DIURIL SODIUM 500 MG VIAL new manufacturer/strength
50383023310 Dorzolamide Hydrochloride and Timolol Maleate 20; 5mg/mL; mg/mL 1 BOTTLE, DROPPER in 1 BOX / 10 mL new manufacturer
00641602010 duramorph 0.5 mg/ml ampule new manufacturer/strength
00037024523 DYMISTA NASAL SPRAY new drug
15054053006 Dysport 3001/1 1 VIAL in 1 CARTON / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL new drug
00002512377 EFFIENT 10 MG TABLET new package size
00430017123 Enablex 15mg/1 90 TABLET, EXTENDED RELEASE in 1 BOTTLE new strength
62037086320 ENOXAPARIN 100 MG/ML SYRINGE new strength
45963043864 ENULOSE 10 GM/15 ML SOLUTION new manufacturer
10802120200 ERGOMAR 2 MG TABLET SL new drug
24338013013 ERYPED 400 MG/5 ML SUSPENSION new strength
00591041401 ESTROPIPATE 0.625(0.75 MG) TABLET new strength
00145006100 EVOCLIN 10mg/g 1 CAN in 1 CARTON / 100 g in 1 CAN new drug
68180036102 fenofibrate 145 mg tablet new strength
16110081230 FLUOROPLEX 1% CREAM new manufacturer
51672406201 FLUOROURACIL 2% TOPICAL SOLN new manufacturer/strength
63323011751 fluorouracil 500 mg/10 ml vial new strength
49909001030 FORFIVO XL 450 MG TABLET new drug
13533063512 GamaSTAN S/D 0.165g/mL new drug
60432003864 GENERLAC 10 GM/15 ML SOLUTION new drug
65649010202 GIAZO 180 GM new drug
68012000316 GLUMETZA ER 1,000 MG TABLET new strength
00062021460 Grifulvin V 500mg/1 100 TABLET BOTTLE new drug
64980018601 griseofulvin micro 500 mg tab new drug
64980018501 griseofulvin ultra 250 mg tab new drug/strength
63004773101 H.P. Acthar 80[USP'U]/mL new drug
60505264107 Hydrochlorothiazide 50mg/1 new strength
51672406104 HYDROCORTISONE 0.1% SOLN new strength/form
00603396828 Hydroxyzine Hydrochloride new manufacturer
49281025051 IMOVAX RABIES VACCINE new drug
00006047761 ISENTRESS 100 MG TABLET CHEW new strength
00228263111 ISOSORBIDE MN 10 MG TABLET new strength
43538053110 ketodan 2% foam kit new drug
00641604225 ketorolac 30 mg/ml vial new strength
66220071930 KRISTALOSE 10 GM PACKET new drug/strength
25010080568 LACRISERT 5 MG EYE INSERT new drug
00338011704 LACTATED RINGERS INJECTION new strength
00456120130 LINZESS 145 MCG CAPSULE new drug/strength
14290031360 Locoid Lipocream 1.0mg/g 1 TUBE in 1 CARTON / 60 g in 1 TUBE new strength
00591024101 Lorazepam 1mg/1 100 TABLET BOTTLE new manufacturer
24208050307 LOTEMAX 0.5% OPHTHALMIC GEL new package size
00145002100 LUXIQ 1.2mg/g 1 CAN in 1 CARTON / 100 g in 1 CAN new drug
00071102001 LYRICA 20 MG/ML ORAL SOLUTION new strength
68453099410 Magnacet 400; 10mg/1; mg/1 new strength
00006026718 MAXALT 10mg/1 18 POUCH in 1 CARTON / 1 TABLET in 1 POUCH new strength
00603441621 Meperidine Hydrochloride 100mg/1 100 TABLET BOTTLE, PLASTIC new manufacturer
00378071101 Methyldopa and Hydrochlorothiazide 25; 250mg/1; mg/1 100 TABLET BOTTLE, PLASTIC new strength
43386014028 Methylergonovine Maleate 0.2mg/1 28 TABLET BOTTLE new package size
00093529501 METHYLPHENIDATE CD 10 MG CAP new manufacturer
63323025803 methylprednisolone 125 mg vial new strength
00093220305 Metoclopramide 10mg/1 500 TABLET BOTTLE new manufacturer
43386016101 misoprostol 200 mcg tablet new manufacturer
00378557301 MODAFINIL 100 MG TABLET new drug/strength
65862056805 montelukast sod 5 mg tab chew new drug/strength
59011026310 MS Contin 100mg/1 new strength
68850001201 MYAMBUTOL 400 MG TABLET new drug
00469260171 MYRBETRIQ ER 25 MG TABLET new drug/strength
00115531101 NADOLOL-BENDROFLU 40-5 MG TAB new strength
50474080103 NEUPRO 1 MG/24 HR PATCH new drug/strength
00085081930 NITRO-DUR 0.8 MG/HR PATCH new drug/strength
55566150101 novarel 10,000 units vial new drug
00093718101 Ofloxacin 300mg/1 100 TABLET, FILM COATED in 1 BOTTLE new strength
00093550656 OLANZAPINE-FLUOXETINE 12-25 MG new drug/strength
55111015611 ONDANSETRON HCL 24 MG TABLET new manufacturer/strength
62584081301 Oxazepam 15mg/1 new strength
10337035830 OXISTAT 1% CREAM new manufacturer/delivery
60505366903 PAXIL 25mg/1 new strength
59767001602 PERTZYE DR 16,000 UNITS CAPS new drug/strength
00143145505 Phenobarbital 60mg/1 new manufacturer/strength
00378004877 pioglitazone hcl 15 mg tablet new drug/strength
00378157591 PIOGLITAZONE-METFORMIN 15-850 new drug/strength
00264762800 POTASSIUM CHLORIDE IN DEXTROSE 5; 0.3g/100mL; g/100mL 12 CONTAINER in 1 CASE / 1000 mL in 1 CONTAIN new manufacturer
00245007111 POTASSIUM CITRATE ER 10 MEQ TB new drug/strength
00378171105 Pramipexole Dihydrochloride 1mg/1 500 TABLET BOTTLE, PLASTIC new manufacturer/strength
55566930002 PREPOPIK POWDER PACKET new drug
64980030230 procto-pak 1% cream new drug
64980030130 proctozone-hc 2.5% cream new drug
24478020020 QUILLIVANT XR 25 MG/5 ML SUSP new drug
61958100401 RANEXA ER 1,000 MG TABLET new strength
75987002201 RAYOS DR 5 MG TABLET new drug/strength
23710090201 reprexain 10-200 mg tablet new drug/strength
49702022517 RESCRIPTOR 200 MG TABLET new product code
23635058210 ROXICODONE 30 MG TABLET new strength
60505343808 SELEGILINE HCL 5 MG TABLET new delivery form
00378165777 SILDENAFIL 20 MG TABLET new drug
00006911780 SINGULAIR 10 MG TABLET new package size
49281018371 SKLICE 0.5% LOTION new drug
00378512401 Sotalol Hydrochloride 120mg/1 100 TABLET BOTTLE, PLASTIC new drug
50419017103 STIVARGA 40 MG TABLET new drug
61958120101 STRIBILD TABLET new drug
20482001230 SUBSYS 1,200 MCG SPRAY new drug/strength
55390031510 Sumatriptan Succinate 6mg/0.5mL 10 VIAL in 1 BOX / 0.5 mL in 1 VIAL new manufacturer
27437020311 SUPRAX 100 MG TABLET CHEWABLE new manufacturer
10337016230 TEMOVATE 0.05% OINTMENT new manufacturer
51672130200 TERCONAZOLE 0.8% CREAM new strength
49281082010 tetanus toxoid adsorbed vial new drug
51079056720 Thioridazine Hydrochloride 50mg/1 100 BLISTER PACK in 1 BOX, UNIT-DOSE / 1 TABLET, FILM COATED in 1 new manufacturer
62756020083 tiagabine hcl 2 mg tablet new drug/strength
00029657126 TIMENTIN ADD-VANTAGE 1; 30mg/mL; mg/mL 10 VIAL in 1 TRAY / 50 mL in 1 VIAL new package size
43386055004 tinidazole 250 mg tablet new drug/strength
00093207501 TOLMETIN SODIUM 400 MG CAP new strength
60505352705 tolterodine tartrate 1 mg tab new drug/strength
51672526303 Topicort 0.5mg/g 1 TUBE in 1 CARTON / 60 g in 1 TUBE new product code
10019055301 TRANSDERM-SCOP 1.5 MG/72HR new drug
00173075049 TREXIMET 500; 85mg/1; mg/1 new drug
00456080060 TUDORZA PRESSAIR 400 MCG INH new drug
00178061501 urocit-k 15.000000meq/1 100 TABLET, EXTENDED RELEASE in 1 BOTTLE new drug
58914078510 Urso 250 250mg/1 new strength
68462047301 Ursodiol 250mg/1 new manufacturer
52937000120 VASCEPA 1 GM CAPSULE new drug
58914011210 VIOKACE 10,440-39,150 UNITS TB new drug/strength
00187000714 VIRAZOLE 6 GM VIAL new drug
00781341694 VORICONAZOLE 200 MG VIAL new manufacturer
68774060001 VOSPIRE ER 4 MG TABLET new drug/strength
00187073130 WELLBUTRIN XL 300 MG TABLET new strength
00069100101 XELJANZ 5 MG TABLET new drug
00187510401 XERESE 5%-1% CREAM new drug
00469012599 XTANDI 40 MG CAPSULE new drug
63402073760 ZETONNA 37 MCG NASAL SPRAY new drug
00069305175 ZITHROMAX 1g/1 3 POWDER, FOR SUSPENSION in 1 BOX new strength
64896068151 ZOMIG 5 MG NASAL SPRAY new delivery form
00187099445 ZOVIRAX 5% CREAM new delivery form
00002411230 Zyprexa 2.5mg/1 30 TABLET BOTTLE new strength

In addition to the above major additions and deletions, individual Medicare Part D plan formularies may have added and/or dropped medications, changed drug tiers, and changed drug usage management requirements. You can review any Medicare plan formulary using the Q1Medicare.com FormularyBrowser at Q1Medicare.com/FormularyBrowser.

Changes to the Top Medicare Drugs:






Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs




Pets are Family Too!
Use your drug discount card to save on medications for the entire family ‐ including your pets.

  • No enrollment fee and no limits on usage
  • Everyone in your household can use the same card, including your pets
Your drug discount card is available to you at no cost.




Tips & Disclaimers
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDP-Compare.com and MA-Compare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.